We disclose the first total synthesis
of (+)-euphorikanin A, an
ingenane-derived natural product featuring an unprecedented 5/6/7/3-fused
tetracyclic skeleton. Key to the approach is a SmI2-mediated
ketyl–enoate reaction that leads to the formation of two rings
in a single step. The polarity-reversed cyclization proceeds in excellent
yield and high diastereoselectivity. Access to ring B is effected
late in the synthesis by implementation of a number of chemoselective
transformations, including in situ generation of a vinyl lithium species
and subsequent intramolecular attack onto an α-ketolactone.
The veterinary drug Alfaprostol and prostaglandin PGF have been synthesized in just nine steps. The strategy involved the conjugate addition of an alkyne to a bicyclic enal, available in three steps by a proline-catalyzed aldol reaction of succinaldehyde. In the case of Alfaprostol, this resulted in the shortest synthesis reported to date. For PGF, this approach improved our previous route by making the 1,4-addition and ozonolysis more operationally simple.
Three new α,α-diazidated azido esters derived from malonic acid were synthesized and characterized with a method of diazidation under mild reaction conditions. They are energy-rich, small, liquid molecules which contain up to six azido moieties. The three synthesized compounds were compared to already known azidated malonic acid esters regarding their density, thermal stability, calculated heat of formation and energetic properties. Further they were tested and classified for their sensitivities according to UN guidelines. Scheme 1. Desired geminal diazidated azido malonic acid ester compounds.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.